Veridian Healthcare
Private Equity Round in 2023
Veridian Healthcare specializes in the development and manufacturing of diagnostic and durable medical equipment for the healthcare industry. The company offers a wide range of products, including blood glucose monitors, digital blood pressure monitors, nebulizers, humidifiers, pulse oximeters, and respiratory care devices. Additionally, Veridian provides creams, ointments, and various pain management solutions, along with fitness and well-being products. By focusing on both professional and home diagnostics, Veridian Healthcare aims to deliver high-quality products that meet the rigorous standards and demands of healthcare professionals.
GaXtracts
Venture Round in 2020
GaXtracts, LLC is a manufacturer of industrial hemp products based in Atlanta, Georgia, established in 2016. The company specializes in producing cannabidiol (CBD) and various hemp-derived products, including tinctures, capsules, and topicals. In response to the COVID-19 pandemic, GaXtracts also began producing a medical-grade hand sanitizer, meeting the needs of hospitals, law enforcement, and healthcare providers. The company collaborates with farmers who cultivate high-quality organic hemp, which is processed at its pharmaceutical-grade facility. Here, the hemp undergoes extraction to isolate CBD, allowing GaXtracts to supply essential ingredients for innovative products in the market. GaXtracts sells its products online, catering to a diverse customer base.
GaXtracts
Debt Financing in 2020
GaXtracts, LLC is a manufacturer of industrial hemp products based in Atlanta, Georgia, established in 2016. The company specializes in producing cannabidiol (CBD) and various hemp-derived products, including tinctures, capsules, and topicals. In response to the COVID-19 pandemic, GaXtracts also began producing a medical-grade hand sanitizer, meeting the needs of hospitals, law enforcement, and healthcare providers. The company collaborates with farmers who cultivate high-quality organic hemp, which is processed at its pharmaceutical-grade facility. Here, the hemp undergoes extraction to isolate CBD, allowing GaXtracts to supply essential ingredients for innovative products in the market. GaXtracts sells its products online, catering to a diverse customer base.
Belladoggie
Debt Financing in 2011
Belladoggie creates a fitness plan for dogs that have had an injury, surgery or are becoming less agile as they age.
The company ensures that pets receive care and attention. The company posts treat, spas, medications, and supplements for dogs.
Belladoggie
Debt Financing in 2010
Belladoggie creates a fitness plan for dogs that have had an injury, surgery or are becoming less agile as they age.
The company ensures that pets receive care and attention. The company posts treat, spas, medications, and supplements for dogs.
Belladoggie
Debt Financing in 2009
Belladoggie creates a fitness plan for dogs that have had an injury, surgery or are becoming less agile as they age.
The company ensures that pets receive care and attention. The company posts treat, spas, medications, and supplements for dogs.
Cardax Pharma
Venture Round in 2004
Cardax, Inc. is a biopharmaceutical company based in Honolulu, Hawaii, specializing in the development and commercialization of dietary supplements and pharmaceutical products targeting inflammatory health and chronic diseases driven by oxidative stress. The company's flagship product, ZanthoSyn, is an anti-inflammatory dietary supplement that utilizes astaxanthin, known for its enhanced absorption and purity, to promote health and longevity. Cardax sells ZanthoSyn primarily through e-commerce and wholesale channels while exploring additional therapeutic options. The company is also developing pharmaceutical candidates such as CDX-101 and CDX-301, which focus on astaxanthin and zeaxanthin, respectively, for various medical conditions. Furthermore, Cardax has established strategic partnerships, including a joint development agreement with BASF SE and a collaboration with Capsugel US, LLC, to enhance its product offerings in the consumer health market. The company's innovative approach aims to address significant unmet medical needs across a range of conditions, including metabolic diseases, cardiovascular issues, and arthritis, with an emphasis on safety and efficacy.